Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate dehydrogenase phosphatase regulatory subunit 2, pseudogene (PDPR2P), is a defective, noncoding copy of the gene encoding a protein involved in the regulation of pyruvate dehydrogenase phosphatase[4][2]. Pseudogenes are DNA segments similar to functional genes but contain disabling mutations, such as frameshifts or premature stop codons, preventing the synthesis of a functional protein[2]. While some pseudogenes can exert regulatory effects on parental gene expression (such as acting as microRNA decoys or competing for regulatory RNA elements), PDPR2P itself has not been associated with any characterized function or disease, and is considered a non-functional gene remnant in the human genome[4][2]. In summary, PDPR2P is correctly classified as a pseudogene; it is not a therapeutic target, does not encode a protein, and has no known biological, pathological, or pharmacological roles[4][2].
None. As a noncoding pseudogene, there are no mechanisms of action for drugs targeting this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate dehydrogenase phosphatase regulatory subunit 2, pseudogene (PDPR2P).